297 related articles for article (PubMed ID: 10391221)
1. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
[TBL] [Abstract][Full Text] [Related]
2. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
Fleming JC; Tartaglini E; Steinkamp MP; Schorderet DF; Cohen N; Neufeld EJ
Nat Genet; 1999 Jul; 22(3):305-8. PubMed ID: 10391222
[TBL] [Abstract][Full Text] [Related]
3. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N
Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303
[TBL] [Abstract][Full Text] [Related]
5. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
[TBL] [Abstract][Full Text] [Related]
6. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
[TBL] [Abstract][Full Text] [Related]
7. Localization of the thiamine-responsive megaloblastic anemia syndrome locus to a 1.4-cM region of 1q23.
Banikazemi M; Diaz GA; Vossough P; Jalali M; Desnick RJ; Gelb BD
Mol Genet Metab; 1999 Mar; 66(3):193-8. PubMed ID: 10066388
[TBL] [Abstract][Full Text] [Related]
8. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
Olsen BS; Hahnemann JM; Schwartz M; Østergaard E
Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067
[TBL] [Abstract][Full Text] [Related]
9. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
Neufeld EJ; Fleming JC; Tartaglini E; Steinkamp MP
Blood Cells Mol Dis; 2001; 27(1):135-8. PubMed ID: 11358373
[TBL] [Abstract][Full Text] [Related]
10. Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy.
Meire FM; Van Genderen MM ; Lemmens K; Ens-Dokkum MH
Ophthalmic Genet; 2000 Dec; 21(4):243-50. PubMed ID: 11135496
[TBL] [Abstract][Full Text] [Related]
11. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Ricketts CJ; Minton JA; Samuel J; Ariyawansa I; Wales JK; Lo IF; Barrett TG
Acta Paediatr; 2006 Jan; 95(1):99-104. PubMed ID: 16373304
[TBL] [Abstract][Full Text] [Related]
12. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report.
Aycan Z; Baş VN; Cetinkaya S; Ağladioğlu SY; Kendirci HN; Senocak F
J Pediatr Hematol Oncol; 2011 Mar; 33(2):144-7. PubMed ID: 21285901
[TBL] [Abstract][Full Text] [Related]
13. Analysis of slc19a2, on 1q23.3 encoding a thiamine transporter as a candidate gene for type 2 diabetes mellitus in pima indians.
Thameem F; Wolford JK; Bogardus C; Prochazka M
Mol Genet Metab; 2001 Apr; 72(4):360-3. PubMed ID: 11286512
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a murine high-affinity thiamine transporter, Slc19a2.
Fleming JC; Steinkamp MP; Kawatsuji R; Tartaglini E; Pinkus JL; Pinkus GS; Fleming MD; Neufeld EJ
Mol Genet Metab; 2001; 74(1-2):273-80. PubMed ID: 11592824
[TBL] [Abstract][Full Text] [Related]
15. Slc19a2: cloning and characterization of the murine thiamin transporter cDNA and genomic sequence, the orthologue of the human TRMA gene.
Oishi K; Hirai T; Gelb BD; Diaz GA
Mol Genet Metab; 2001 Jun; 73(2):149-59. PubMed ID: 11386850
[TBL] [Abstract][Full Text] [Related]
16. Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity.
Raz T; Barrett T; Szargel R; Mandel H; Neufeld EJ; Nosaka K; Viana MB; Cohen N
Hum Genet; 1998 Oct; 103(4):455-61. PubMed ID: 9856490
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
Gritli S; Omar S; Tartaglini E; Guannouni S; Fleming JC; Steinkamp MP; Berul CI; Hafsia R; Jilani SB; Belhani A; Hamdi M; Neufeld EJ
Br J Haematol; 2001 May; 113(2):508-13. PubMed ID: 11380424
[TBL] [Abstract][Full Text] [Related]
18. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
[TBL] [Abstract][Full Text] [Related]
19. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
[TBL] [Abstract][Full Text] [Related]
20. TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature.
Ozdemir MA; Akcakus M; Kurtoglu S; Gunes T; Torun YA
Pediatr Diabetes; 2002 Dec; 3(4):205-9. PubMed ID: 15016149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
